Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.

Clinical breast cancer

Volumn 1, Issue 2, 2000, Pages

  Gennari, A ^a   Donati, S ^a   Salvadori, B ^a   Giorgetti, A ^a   Salvadori, P A ^a   Sorace, O ^a   Puccini, G ^a   Pisani, P ^a   Poli, M ^a   Dani, D ^a   Landucci, E ^a   Mariani, G ^a   Conte, P F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; GLUCOSE; PACLITAXEL; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BREAST TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG MONITORING; FEMALE; HUMAN; LIVER TUMOR; LUNG TUMOR; METABOLISM; METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; REMISSION; SOFT TISSUE TUMOR; STANDARD; SURVIVAL; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; DRUG MONITORING; EPIRUBICIN; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; PACLITAXEL; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REMISSION INDUCTION; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0034236325     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/cbc.2000.n.014     Document Type: Article

References (0)